RP
ROHIT PAL
Acharya & BM Reddy College of Pharmacy College, Acharya and BM Reddy College of Pharmacy
Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds · Computational Drug Discovery Methods
0000-0002-2763-5757
Employment
-
Acharya & BM Reddy College of Pharmacy College Junior Research scholar2022 - 2024
Education
-
Acharya and BM Reddy College of Pharmacy Junior Research scholar (ICMR)/ PhD scholar2022 - 2025
Projects & Funding
Projects & funding information is unavailable.
Publications (39)
- Fused tricyclic aromatic and heteroaromatic scaffolds as anticancer agents: Recent advances in medicinal chemistry, structure–activity relationships, and therapeutic potential Save
- Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N‐Cinnamamide/Benzamide‐(4‐(Substituted Phenyl)‐6‐(4‐Cyclohexylphenyl)pyrimidin‐2‐yl) Derivatives as EGFR Inhibitors Targeting EGFRWT, EGFRT790M, and EGFRL858R/T790M/C797S in NSCLC Save
- Recent Advances in Microwave and Ultrasound Assisted Synthesis of Quinoline Derivatives as Anticancer Agents Save
- Design, Synthesis, and Molecular Docking Studies of Coumarin-chalcone Conjugates as Selective TNF-α and Weak COX-2 Inhibitors with Efficacy as an Antioxidant Save
- Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure–activity relationship insights Save
- Medicinal chemistry perspective on quinazoline derivatives: Sustainable synthetic routes, anticancer evaluation, and SAR analysis Save
- Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives Save
- Multistage Computational Evaluation of Bedaquiline Pyridyl Derivatives: Unveiling Anti‐Tubercular Potential Through QSAR, Molecular Docking, Molecular Dynamics, ADMET, and DFT Analysis Save
- Design, Synthesis, In Silico, and In Vitro Study of Substituted Phenyl Thiazole‐Pyrimidine/Pyridine Containing Derivatives as Anticancer Agents Save
- Design, Synthesis, and Molecular Profiling of Pyrimidine‐Furan Derivatives Targeting EGFRWT, EGFRT790M, and EGFRL858R/T790M/C797S in NSCLC: In Vitro and In Silico Evaluation Save
- Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs Save
- Integrated Computational and Experimental Insights Into MEK1/2 Inhibitors: Structural Validation, Docking, ADMET, Molecular Dynamics, and Anticancer Evaluation Save
- Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure–activity relationship Save
- Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration Save
- Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance Save
- An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC) Save
- Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies Save
- Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR) Save
- Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents Save
- Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights Save